Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomab

Blinatumomab for Infant Acute Lymphoblastic Leukaemia

(2020) Katherine Clesham et al.   BLOOD

Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia

(2020) Franco Locatelli et al.   LEUKEMIA

Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B‐acute lymphoblastic leukemia

(2020) Cristina F. Contreras et al.   PEDIATRIC BLOOD & CANCER

Durable remissions in TCF3-HLF positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation

(2019) Brice Mouttet et al.   HAEMATOLOGICA

Prognostic factors for survival after relapsed acute lymphoblastic leukemia (ALL): A Children’s Oncology Group (COG) study.

(2019) Susan R. Rheingold et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial

(2019) Catriona Parker et al.   Lancet Haematology

Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study

(2018) Weili Sun et al.   LEUKEMIA

Novel Therapies in Acute Lymphoblastic Leukemia

(2018) Kathleen W. Phelan et al.   Current Hematologic Malignancy Reports

High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment

(2017) Susan L. Heatley et al.   HAEMATOLOGICA

The MLL recombinome of acute leukemias in 2017

(2017) C Meyer et al.   LEUKEMIA

High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment

(2017) Susan L. Heatley et al.   HAEMATOLOGICA

Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia

(2016) Julie A. E. Irving et al.   BLOOD

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

(2016) Arend von Stackelberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

(2010) V. Conter et al.   BLOOD

Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study

(2008) K Nguyen et al.   LEUKEMIA